Arcadia Biosciences, Inc. (NASDAQ:RKDA) Sees Large Decrease in Short Interest

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totaling 18,768 shares, a decline of 78.8% from the August 15th total of 88,674 shares. Based on an average daily volume of 183,620 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.8% of the company’s stock are short sold.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.

Arcadia Biosciences Price Performance

NASDAQ RKDA traded down $0.02 during trading hours on Friday, hitting $0.43. The company’s stock had a trading volume of 19,052 shares, compared to its average volume of 125,251. Arcadia Biosciences has a 12 month low of $0.38 and a 12 month high of $6.71. The company’s 50 day simple moving average is $0.59 and its two-hundred day simple moving average is $1.01. The company has a market cap of $1.04 million, a P/E ratio of -0.09 and a beta of 0.53.

Arcadia Biosciences (NASDAQ:RKDA) last posted its earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative net margin of 234.53% and a negative return on equity of 183.50%. The company had revenue of $1.44 million for the quarter, compared to the consensus estimate of $1.90 million.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.